Foetal alcohol spectrum disorder in Aotearoa, New Zealand: Estimates of prevalence and indications of inequity
- PMID: 36809679
- DOI: 10.1111/dar.13619
Foetal alcohol spectrum disorder in Aotearoa, New Zealand: Estimates of prevalence and indications of inequity
Abstract
Introduction: Foetal alcohol spectrum disorder (FASD) is 100% caused by alcohol. The lifelong disability caused by prenatal alcohol exposure cannot be reversed. Lack of reliable national prevalence estimates of FASD is common internationally and true of Aotearoa, New Zealand. This study modelled the national prevalence of FASD and differences by ethnicity.
Methods: FASD prevalence was estimated from self-reported data on any alcohol use during pregnancy for 2012/2013 and 2018/2019, combined with risk estimates for FASD from a meta-analysis of case-ascertainment or clinic-based studies in seven other countries. A sensitivity analysis using four more recent active case ascertainment studies was performed to account for the possibility of underestimation.
Results: We estimated FASD prevalence in the general population to be 1.7% (95% confidence interval [CI] 1.0%; 2.7%) in the 2012/2013 year. For Māori, the prevalence was significantly higher than for Pasifika and Asian populations. In the 2018/2019 year, FASD prevalence was 1.3% (95% CI 0.9%; 1.9%). For Māori, the prevalence was significantly higher than for Pasifika and Asian populations. The sensitivity analysis estimated the prevalence of FASD in the 2018/2019 year to range between 1.1% and 3.9% and for Māori, from 1.7% to 6.3%.
Discussion and conclusions: This study used methodology from comparative risk assessments, using the best available national data. These findings are probably underestimates but indicate a disproportionate experience of FASD by Māori compared with some ethnicities. The findings support the need for policy and prevention initiatives to support alcohol-free pregnancies to reduce lifelong disability caused by prenatal alcohol exposure.
Keywords: alcohol consumption during pregnancy; foetal alcohol spectrum disorder (FASD); inequity Aotearoa/New Zealand; prevalence.
© 2023 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.
References
REFERENCES
-
- Shield KD, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry CDH, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5:E51-61.
-
- Meng X, Brunet A, Turecki G, Liu A, D'Arcy C, Caron J. Risk factor modifications and depression incidence: a 4-year longitudinal Canadian cohort of the Montreal catchment area study. BMJ Open. 2017;7:e015156.
-
- World Health Organization. Global alcohol action plan 2022-2030 to strengthen implementation of the Global Strategy to Reduce the Harmful Use of Alcohol - First draft. 2021 [updated July; cited 2021]. Available from: https://cdn.who.int/media/docs/default-source/alcohol/alcohol-action-pla....
-
- Harding K, Flannigan K, McFarlane A. Policy action paper: toward a standard definition of fetal alcohol spectrum disorder in Canada. Vancouver, BC: CanFASD Canada Fetal Alcohol Spectrum Disorder Research Network; 2019 Available from: https://canfasd.ca/wp-content/uploads/2019/08/Toward-a-Standard-Definiti...
-
- Williams JF, Smith VC. Fetal alcohol spectrum disorders. Pediatrics. 2015;136:e1395-e406.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
